| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 Nov 2025 | 3 Nov 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Pursuant to Regulations 29 & 30 of SEBI (LODR) Regulations 2015 notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday November 11 2025 at the Registered Office to consider and approve: (1) Unaudited Standalone & Consolidated Financial Results along with Limited Review Report for the quarter ended September 30 2025; (2) To take note of the resignation of CS Siddhi Shah Company Secretary & Compliance Officer w.e.f. September 26 2025; (3) To consider appointment of CS Chaitra Arora (A78376) as Company Secretary & Compliance Officer; and (4) Any other business with permission of the Chair. The notice is available on the Companys website: https://vivanzabiosciences.com/announcement/ . The trading window remains closed till 48 hours after declaration of the said results. Pursuant to Regulation 30 and 33 of the SEBI (LODR) Regulations, 2015 we wish to inform that the board of directors at its meeting held tuesday 11th November, 2025 has inter alia considered and approved (1) unaudited standalone and consolidated financial results for the quarter ended 30th September, 2025 alongwith the limited review report (2) Appointment of CS Chaitra Arora (M.No. A78376) as Company Secretary & compliance officer and noted the resignation of CS siddhi shah (M. No. A44885) (3) Alteration of main object clause of the Memorandum of association to include manufacturing and trading of plastic and packaging materials subject to shareholders approval via postal ballot (4) Approval of postal ballot notice, calendar of events, cut- off date of 7th November, 2025 and appointment of Mr. Chintan K. Patel as a Scrutinizer. Pursuant to Regulations 30 and 33 of the SEBI (LODR) Regulations, 2015, we wish to inform that the Board of Directors, at its meeting held on Tuesday, 11th November, 2025, has inter alia considered and approved: (1) Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2025, along with the Limited Review Report; (2) Appointment of CS Chaitra Arora (M. No. A78376) as Company Secretary & Compliance Officer and noted the resignation of CS Siddhi Shah (M. No. A44885); (3) Alteration of the Main Object Clause of the Memorandum of Association to include manufacturing and trading of plastic and packaging materials, subject to shareholders approval via Postal Ballot; (4) Approval of Postal Ballot Notice, Calendar of Events, cut-off date of 7th November, 2025, and appointment of Mr. Chintan K. Patel, PCS, as Scrutinizer (As Per BSE Announcement Dated on:11.11.2025) Pursuant to regulations 30 & 33 of SEBI (LODR), we inform that the Board at its meeting held on November 11, 2025, approved: 1. Un-audited & Standalone Financial results for the quarter ended 3.09.2025, along with a limited review report. 2. Appointment of CS Chaitra Arora (M. No.: A78376) as Company Secretary and Compliance Officer 3. Noted resignation of CS Siddhi Shah (A44885) w.e.f 26.09.2025 4. Alteration of the main object clause of the MOA , subject to approvals, related disclosure enclosed. 5. Approval of revised Object clause to include activities relating to plastic polymer films, packaging material, etc., subject to postal ballot approval. 6. Approval of Postal Ballot Calendar, Postal Ballot Notice Cut-off date 07-11-2025, and appointment of Scrutinizer Mr. Chintan K. Patel (M. No.: A31987) (As Per BSE Announcement Dated on:14.11.2025) | ||
| Board Meeting | 1 Sep 2025 | 28 Aug 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2025 inter alia to consider and approve 1)The Directors Report and Secretarial Audit Report alongwith annexure for the Financial Year 2024-25. 2)To Convene the 43rd Annual General Meeting (AGM) of the Members of the Company and approve the draft notice of 43rd Annual General Meeting (AGM) of the Company. 3)To fix the cut-off date for e-voting for the 43rdAnnual General Meeting of the Company. 4)To appoint Mr. Chintan K. Patel Practicing Company Secretary (Mem No: A31987 COP: 11959) as a Scrutinizer to ascertain voting process of 43rd Annual General Meeting (AGM).5)To appoint Mr. Chintan K. Patel Practicing Company Secretary (Mem No: A31987 COP: 11959) Ahmedabad as the Secretarial Auditors of the Company for the period of five consecutive financial years i.e. from F.Y. 2025-26 to 2029-30 and 6)To consider any other matter with the permission of the Chair. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Monday, 1st September, 2025 has discussed agendas as described in Outcome. (As per BSE Announcement Dated on 01/09/2025) | ||
| Board Meeting | 30 Aug 2025 | 30 Aug 2025 |
| Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that based on the recommendation of the Nomination & Remuneration Committee, the Board at its meeting held today i.e. August 30, 2025 has approved the appointment of Mr. Sarang Bharatbhai Pathak (DIN: 02663344) as Additional Director (Non-Executive - Non Independent) of the Company subject to the approval of the shareholders of the Company in the General Meeting. | ||
| Board Meeting | 13 Aug 2025 | 8 Aug 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve the Un-audited Standalone and Consolidated Financial results along with the Limited Review Report of the Company for the Quarter ended 30th June 2025 and any other business with the permission of the Chair. The Board of Directors of the Company at its meeting held today i.e. Wednesday , August 13, 2025 at Registered Office of the Company has inter alia considered and approved the Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter ended on 30th June, 2025. (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 12 May 2025 | 6 May 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve The Audited Standalone and Consolidated Financial statements and Financial results of the Company for the quarter and year ended March 31 2025 and 2. Any other business with the permission of Chair. Audited Standalone and Consolidated Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended 31st March, 2025. The Board of Directors of the Company at its meeting held today i.e. Monday, 12th May, 2025 at Registered Office of the Company has inter alia considered and approved the following businesses: 1.Audited Standalone and Consolidated Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended 31stMarch, 2025 . 2. Appointment of M/s. Rahul Doshi & Co., Chartered Accountants (FRN: 150982W, Membership No. 117160) as Internal Auditor of the Company for the Financial year 2025-26. 3. Appointment of Mr. Chintan K. Patel, Practicing Company Secretary (Membership No. A31987, COP: 11959) as Secretarial Auditor of the Company for the Financial year 2024-25.4. Appointment of Mr. Hitesh Pradeep Rijwani (DIN: 11030634) as an Additional Director (Non- Executive, Independent Director) and 5. Reconstitution of Committees of the Board w.e.f. 12thMay, 2025. (As Per BSE Announcement Dated on: 12/05/2025) Revised Outcome of the Board Meeting pertaining to clarification on Typographical Error in the Notes related to Financial Results submission for the quarter and year ended March 31, 2025 (As Per BSE Announcement Dated on 13.05.2025) | ||
| Board Meeting | 20 Mar 2025 | 20 Mar 2025 |
| Appointment of Ms. Siddhi Shah as Company Secretary w.e.f. 20.03.2025 | ||
| Board Meeting | 31 Jan 2025 | 24 Jan 2025 |
| Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve 1. Unaudited Standalone and Consolidated Results along with Limited Review Report for the Quarter and Nine Months ended 31st December 2024; 2. Any other business with the permission of Chairman. Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. inter alia considered and approved Un-audited Financial Results for the Quarter and Nine Months Ended 31st December, 2024. (As Per BSE Announcement Dated on: 31/01/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.